| Dr James Henry Golleher Sr, MD | |
|
1915 W Beebe Capps Expy, Searcy, AR 72143-5012 | |
| (501) 268-8175 | |
| (501) 268-8337 |
| Full Name | Dr James Henry Golleher Sr |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 54 Years |
| Location | 1915 W Beebe Capps Expy, Searcy, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356319438 | NPI | - | NPPES |
| 18019 | Other | AR | MEDICARE GROUP |
| 71044582830 | Other | AR | QUALCHOICE |
| 56822 | Other | AR | MEDICARE PROFESSIONAL |
| Facility Name | Location | Facility Type |
|---|---|---|
| White County Medical Center | Searcy, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lab Of Path, Pa | 2062510076 | 2 |
| White County Medical Center | 4880688654 | 149 |
News Archive
Eleven Biotherapeutics (NASDAQ: EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced that patient randomization and dosing are underway in the Company's first pivotal Phase 3 clinical study of EBI-005 for the treatment of moderate to severe dry eye disease (DED), the OASIS study (A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Control In Subjects With Moderate to Severe Dry Eye Disease).
Every parent of a young child knows how emotionally attached children can become to a soft toy or blanket that they sleep with every night.
Half of all lifetime mental illness begins by age 14, with one in five children affected by mental illness and often not getting treatment for years.
Senior drivers who always take a pet in the car are at increased risk for being involved in a motor vehicle collision, said University of Alabama at Birmingham researchers.
› Verified 2 days ago
| Entity Name | Lab Of Path, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639397953 PECOS PAC ID: 2062510076 Enrollment ID: O20070614000063 |
News Archive
Eleven Biotherapeutics (NASDAQ: EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced that patient randomization and dosing are underway in the Company's first pivotal Phase 3 clinical study of EBI-005 for the treatment of moderate to severe dry eye disease (DED), the OASIS study (A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Control In Subjects With Moderate to Severe Dry Eye Disease).
Every parent of a young child knows how emotionally attached children can become to a soft toy or blanket that they sleep with every night.
Half of all lifetime mental illness begins by age 14, with one in five children affected by mental illness and often not getting treatment for years.
Senior drivers who always take a pet in the car are at increased risk for being involved in a motor vehicle collision, said University of Alabama at Birmingham researchers.
› Verified 2 days ago
| Entity Name | White County Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053662890 PECOS PAC ID: 4880688654 Enrollment ID: O20130510000018 |
News Archive
Eleven Biotherapeutics (NASDAQ: EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced that patient randomization and dosing are underway in the Company's first pivotal Phase 3 clinical study of EBI-005 for the treatment of moderate to severe dry eye disease (DED), the OASIS study (A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Control In Subjects With Moderate to Severe Dry Eye Disease).
Every parent of a young child knows how emotionally attached children can become to a soft toy or blanket that they sleep with every night.
Half of all lifetime mental illness begins by age 14, with one in five children affected by mental illness and often not getting treatment for years.
Senior drivers who always take a pet in the car are at increased risk for being involved in a motor vehicle collision, said University of Alabama at Birmingham researchers.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Henry Golleher Sr, MD 1915 W Beebe Capps Expy, Searcy, AR 72143-5012 Ph: (501) 268-8175 | Dr James Henry Golleher Sr, MD 1915 W Beebe Capps Expy, Searcy, AR 72143-5012 Ph: (501) 268-8175 |
News Archive
Eleven Biotherapeutics (NASDAQ: EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, today announced that patient randomization and dosing are underway in the Company's first pivotal Phase 3 clinical study of EBI-005 for the treatment of moderate to severe dry eye disease (DED), the OASIS study (A Multi-Center, Double-Masked, Randomized, Controlled, Efficacy and Safety Study of EBI-005 5 mg/mL Topical Ophthalmic Solution Versus Vehicle Control In Subjects With Moderate to Severe Dry Eye Disease).
Every parent of a young child knows how emotionally attached children can become to a soft toy or blanket that they sleep with every night.
Half of all lifetime mental illness begins by age 14, with one in five children affected by mental illness and often not getting treatment for years.
Senior drivers who always take a pet in the car are at increased risk for being involved in a motor vehicle collision, said University of Alabama at Birmingham researchers.
› Verified 2 days ago
Dr. Ruth Ann Reardon, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1915 W Beebe Capps Expy, Searcy, AR 72143 Phone: 501-268-8175 Fax: 501-268-8337 |